Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial (Q42651814)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial |
scientific article |
Statements
1 reference
Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial (English)
1 reference
1 reference
Zahra Pakbaz
1 reference
Elliott Vichinsky
1 reference
Onyinye Onyekwere
1 reference
Paul Swerdlow
1 reference
Thomas Coates
1 reference
Peter Lane
1 reference
Beatrice Files
1 reference
Brigitta U Mueller
1 reference
Lena Coïc
1 reference
Gian Luca Forni
1 reference
Roland Fischer
1 reference
Peter Marks
1 reference
Diana Rofail
1 reference
Linda Abetz
1 reference
Jean-Francois Baladi
1 reference
11 April 2008
1 reference
1 reference
Identifiers
1 reference